// App-Quantinova.ai

4468 : Targeted deep sequencing of plasma circulating cell-free DNA shows VIM and FBLN1 methylation as potential biomarkers for hepatocellular carcinoma

Researchers

Presenter

  • Reetta Holmila

Principal Investigators

  • Athena Sklias

  • David C. Muller

  • Davide Degli Esposti

  • Paule Guilloreau

  • James Mckay

  • Suleeporn Sangrajrang

  • Petcharin Srivatanakul

  • Pierre Hainaut

  • Philippe Merle

  • Andre Nogueira da Costa

  • Zdenko Herceg

Medical Centers

  • International Agency for Research on Cancer, Lyon, France

  • Croix-Rousse Hospital, Lyon, France

  • National Cancer Institute, Bangkok, Thailand

  • Institut Albert Bonniot, INSERM Unite , La Tronche, France

  • INSERM U1052, Lyon, France

Locations

  • France

  • Thailand

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • Fibulin 1

  • Histidine triad nucleotide-binding 2

  • Latent Transforming Growth Factor Beta Binding Protein 1

  • Latent Transforming Growth Factor Beta Binding Protein 2

  • Transforming Growth Factor Beta 1

  • Vimentin

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved